Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Shanghai Fosun Pharmaceutical (Group)

Market Cap: CN¥76.5b

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Jiangsu Gdk Biological Technology

Market Cap: CN¥1.9b

Engages in the scientific research, production of human vaccines.

ABL Bio

Market Cap: ₩5.1t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

Fuan Pharmaceutical (Group)

Market Cap: CN¥5.1b

Research and develops, produces, and sells chemical drugs in the People's Republic of China.

Kintor Pharmaceutical

Market Cap: HK$1.1b

A clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People’s Republic of China.

RemeGen

Market Cap: HK$63.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.

Radiopharm Theranostics

Market Cap: AU$68.6m

A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.

Dezhan Healthcare

Market Cap: CN¥8.5b

Engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China.

Senores Pharmaceuticals

Market Cap: ₹32.3b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

Asston Pharmaceuticals

Market Cap: ₹849.6m

Engages in the manufacturing pharmaceutical products in India, West Africa, South Africa, and Asian countries.

HansBiomed

Market Cap: ₩234.9b

Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

MGI Tech

Market Cap: CN¥28.0b

Engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally.

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.5b

Shanghai Rightongene Biotechnology Co., Ltd.

Frontage Holdings

Market Cap: HK$2.5b

A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.

Luye Pharma Group

Market Cap: HK$13.4b

Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.

Colinz Laboratories

Market Cap: ₹105.9m

Manufactures, markets, and trades in pharmaceutical formulations in India.

Ortin Global

Market Cap: ₹96.0m

Engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India.

Searle

Market Cap: PK₨60.2b

Manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally.

Ark Solutions

Market Cap: ₩68.9b

Engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally.

Dar Al Dawa Development and Investment

Market Cap: د.أ39.9m

Dar Al Dawa Development and Investment Co.

Spero Therapeutics

Market Cap: US$110.9m

A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.

Matricelf

Market Cap: ₪78.4m

A biotechnology company, develops a platform for autologous tissue engineering for various medical conditions.

Pulmatrix

Market Cap: US$16.6m

A clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States.

VivoSim Labs

Market Cap: US$9.2m

A pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine.

Revvity

Market Cap: US$9.8b

Provides health sciences solutions, technologies, and services.

Alpha Teknova

Market Cap: US$303.4m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Pangaea Oncology

Market Cap: €59.8m

A medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries.

Rhythm Pharmaceuticals

Market Cap: US$6.4b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

BioLight Life Sciences

Market Cap: ₪18.8m

An ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions.

Grace Breeding

Market Cap: ₪82.7m

An agro-tech company, develops nitrogenous and climate change stress relief products in Europe, the United States, South America, and Israel.

NextCure

Market Cap: US$15.4m

A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.

Marker Therapeutics

Market Cap: US$11.8m

A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

SynAct Pharma

Market Cap: SEK 1.1b

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Euroapi

Market Cap: €279.0m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

Enzymatica

Market Cap: SEK 577.7m

A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.

SELLAS Life Sciences Group

Market Cap: US$171.6m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.